Yayın:
Effects of Single and Repeated Doses on Disposition and Kinetics of Doxycycline Hyclate in Goats

dc.contributor.authorTurk, Erdinc
dc.contributor.authorCorum, Orhan
dc.contributor.authorTekeli, Ibrahim Ozan
dc.contributor.authorSakin, Fatih
dc.contributor.authorUney, Kamil
dc.date.accessioned2026-01-04T14:14:58Z
dc.date.issued2020-06-24
dc.description.abstractThe aims of this study in goats were to determine the pharmacokinetics of doxycycline hyclate following single intravenous (IV), intramuscular (IM) and oral administrations of 20 mg/kg and to evaluate the pharmacokinetics and accumulation of doxycycline hyclate after repeated oral administrations at a 20 mg/kg dose every 24 h for 5 days. Six healthy male goats were used for the study. The study was performed in four periods according to a longitudinal study with a 15-day washout period. Plasma concentrations of doxycycline were determined using HPLC-UV and analyzed by a non-compartmental method. IM injection of doxycycline caused swelling and pain due to irritation in the injection site. After IM and oral administrations, terminal elimination half-life (t1/2λz) and mean residence time (MRT) were prolonged and areas under the curve (AUCs) were low. The mean bioavailability of IM and oral administration was 51.51% and 31.39%, respectively. Following repeated oral administration, the accumulation ratio of doxycycline was 1.76. Pharmacokinetic properties including weak accumulation, wide distribution volume and long elimination half-life can make doxycycline hyclate valuable for repeated use via an oral route in the treatment of some infectious diseases in goats. However, the determination of pharmacodynamic effects on susceptible pathogens isolated from goats is also necessary to confirm the drug dosage regimen.
dc.description.urihttps://doi.org/10.3390/ani10061088
dc.description.urihttps://www.mdpi.com/2076-2615/10/6/1088/pdf
dc.description.urihttps://pubmed.ncbi.nlm.nih.gov/32599703
dc.description.urihttp://dx.doi.org/10.3390/ani10061088
dc.description.urihttps://doaj.org/article/9412d4a3b15247bdb29ce8ddd1d3e2e9
dc.description.urihttps://dx.doi.org/10.3390/ani10061088
dc.identifier.doi10.3390/ani10061088
dc.identifier.eissn2076-2615
dc.identifier.openairedoi_dedup___::dee12c1f22844fa17fd952a147e4d161
dc.identifier.orcid0000-0003-3168-2510
dc.identifier.orcid0000-0002-6845-2279
dc.identifier.orcid0000-0002-8674-4873
dc.identifier.pubmed32599703
dc.identifier.scopus2-s2.0-85086875684
dc.identifier.startpage1088
dc.identifier.urihttps://hdl.handle.net/20.500.12597/38045
dc.identifier.volume10
dc.identifier.wos000550869200001
dc.language.isoeng
dc.publisherMDPI AG
dc.relation.ispartofAnimals
dc.rightsOPEN
dc.subjectdoxycycline
dc.subjectVeterinary medicine
dc.subjectgoat
dc.subjectrepeated dose
dc.subjectArticle
dc.subjectoral
dc.subjectQL1-991
dc.subjectSF600-1100
dc.subjectpharmacokinetics
dc.subjectZoology
dc.subject.sdg1. No poverty
dc.subject.sdg3. Good health
dc.titleEffects of Single and Repeated Doses on Disposition and Kinetics of Doxycycline Hyclate in Goats
dc.typeArticle
dspace.entity.typePublication
local.api.response{"authors":[{"fullName":"Erdinc Turk","name":"Erdinc","surname":"Turk","rank":1,"pid":null},{"fullName":"Orhan Corum","name":"Orhan","surname":"Corum","rank":2,"pid":{"id":{"scheme":"orcid","value":"0000-0003-3168-2510"},"provenance":null}},{"fullName":"Ibrahim Ozan Tekeli","name":"Ibrahim Ozan","surname":"Tekeli","rank":3,"pid":{"id":{"scheme":"orcid","value":"0000-0002-6845-2279"},"provenance":null}},{"fullName":"Fatih Sakin","name":"Fatih","surname":"Sakin","rank":4,"pid":null},{"fullName":"Kamil Uney","name":"Kamil","surname":"Uney","rank":5,"pid":{"id":{"scheme":"orcid","value":"0000-0002-8674-4873"},"provenance":null}}],"openAccessColor":"gold","publiclyFunded":false,"type":"publication","language":{"code":"eng","label":"English"},"countries":null,"subjects":[{"subject":{"scheme":"FOS","value":"0301 basic medicine"},"provenance":null},{"subject":{"scheme":"keyword","value":"doxycycline"},"provenance":null},{"subject":{"scheme":"keyword","value":"Veterinary medicine"},"provenance":null},{"subject":{"scheme":"keyword","value":"goat"},"provenance":null},{"subject":{"scheme":"SDG","value":"1. No poverty"},"provenance":null},{"subject":{"scheme":"FOS","value":"04 agricultural and veterinary sciences"},"provenance":null},{"subject":{"scheme":"keyword","value":"repeated dose"},"provenance":null},{"subject":{"scheme":"keyword","value":"Article"},"provenance":null},{"subject":{"scheme":"SDG","value":"3. Good health"},"provenance":null},{"subject":{"scheme":"FOS","value":"0403 veterinary science"},"provenance":null},{"subject":{"scheme":"keyword","value":"oral"},"provenance":null},{"subject":{"scheme":"FOS","value":"03 medical and health sciences"},"provenance":null},{"subject":{"scheme":"keyword","value":"QL1-991"},"provenance":null},{"subject":{"scheme":"keyword","value":"SF600-1100"},"provenance":null},{"subject":{"scheme":"keyword","value":"pharmacokinetics"},"provenance":null},{"subject":{"scheme":"keyword","value":"Zoology"},"provenance":null}],"mainTitle":"Effects of Single and Repeated Doses on Disposition and Kinetics of Doxycycline Hyclate in Goats","subTitle":null,"descriptions":["<jats:p>The aims of this study in goats were to determine the pharmacokinetics of doxycycline hyclate following single intravenous (IV), intramuscular (IM) and oral administrations of 20 mg/kg and to evaluate the pharmacokinetics and accumulation of doxycycline hyclate after repeated oral administrations at a 20 mg/kg dose every 24 h for 5 days. Six healthy male goats were used for the study. The study was performed in four periods according to a longitudinal study with a 15-day washout period. Plasma concentrations of doxycycline were determined using HPLC-UV and analyzed by a non-compartmental method. IM injection of doxycycline caused swelling and pain due to irritation in the injection site. After IM and oral administrations, terminal elimination half-life (t1/2λz) and mean residence time (MRT) were prolonged and areas under the curve (AUCs) were low. The mean bioavailability of IM and oral administration was 51.51% and 31.39%, respectively. Following repeated oral administration, the accumulation ratio of doxycycline was 1.76. Pharmacokinetic properties including weak accumulation, wide distribution volume and long elimination half-life can make doxycycline hyclate valuable for repeated use via an oral route in the treatment of some infectious diseases in goats. However, the determination of pharmacodynamic effects on susceptible pathogens isolated from goats is also necessary to confirm the drug dosage regimen.</jats:p>"],"publicationDate":"2020-06-24","publisher":"MDPI AG","embargoEndDate":null,"sources":["Crossref","Animals (Basel)","Animals, Vol 10, Iss 6, p 1088 (2020)","Animals","Volume 10","Issue 6"],"formats":["application/pdf"],"contributors":null,"coverages":null,"bestAccessRight":{"code":"c_abf2","label":"OPEN","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"Animals","issnPrinted":null,"issnOnline":"2076-2615","issnLinking":null,"ep":null,"iss":null,"sp":"1088","vol":"10","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::dee12c1f22844fa17fd952a147e4d161","originalIds":["ani10061088","10.3390/ani10061088","50|doiboost____|dee12c1f22844fa17fd952a147e4d161","od_______267::2eb2fa72a2847107bf394c750d595b2b","32599703","PMC7341317","oai:pubmedcentral.nih.gov:7341317","50|od_______267::2eb2fa72a2847107bf394c750d595b2b","50|doajarticles::e4d627ce427cbe13b215c7ee68341512","oai:doaj.org/article:9412d4a3b15247bdb29ce8ddd1d3e2e9","3036082389","50|multidiscipl::ff2ce7bf4e35d5422ddaf0cdfc37ec8c","oai:mdpi.com:/2076-2615/10/6/1088/"],"pids":[{"scheme":"doi","value":"10.3390/ani10061088"},{"scheme":"pmid","value":"32599703"},{"scheme":"pmc","value":"PMC7341317"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":13,"influence":3.3140841e-9,"popularity":1.1085347e-8,"impulse":6,"citationClass":"C4","influenceClass":"C4","impulseClass":"C4","popularityClass":"C4"}},"instances":[{"pids":[{"scheme":"doi","value":"10.3390/ani10061088"}],"license":"CC BY","type":"Article","urls":["https://doi.org/10.3390/ani10061088"],"publicationDate":"2020-06-24","refereed":"peerReviewed"},{"pids":[{"scheme":"doi","value":"10.3390/ani10061088"}],"license":"CC BY","type":"Article","urls":["https://www.mdpi.com/2076-2615/10/6/1088/pdf"],"refereed":"nonPeerReviewed"},{"pids":[{"scheme":"pmid","value":"32599703"},{"scheme":"pmc","value":"PMC7341317"}],"alternateIdentifiers":[{"scheme":"doi","value":"10.3390/ani10061088"}],"type":"Article","urls":["https://pubmed.ncbi.nlm.nih.gov/32599703"],"refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.3390/ani10061088"}],"type":"Other literature type","urls":["http://dx.doi.org/10.3390/ani10061088"],"publicationDate":"2020-06-24","refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.3390/ani10061088"}],"type":"Article","urls":["https://doaj.org/article/9412d4a3b15247bdb29ce8ddd1d3e2e9"],"publicationDate":"2020-06-01","refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"mag_id","value":"3036082389"},{"scheme":"doi","value":"10.3390/ani10061088"}],"type":"Article","urls":["https://dx.doi.org/10.3390/ani10061088"],"refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.3390/ani10061088"}],"license":"CC BY","type":"Other literature type","urls":["http://dx.doi.org/10.3390/ani10061088"],"publicationDate":"2020-06-24","refereed":"nonPeerReviewed"}],"isGreen":true,"isInDiamondJournal":false}
local.import.sourceOpenAire
local.indexed.atWOS
local.indexed.atScopus
local.indexed.atPubMed

Dosyalar

Koleksiyonlar